Corifollitropin α followed by menotropin for poor ovarian responders' trial (COMPORT): a protocol of a multicentre randomised trial.
about
Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study.
P2860
Corifollitropin α followed by menotropin for poor ovarian responders' trial (COMPORT): a protocol of a multicentre randomised trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Corifollitropin α followed by ...... multicentre randomised trial.
@en
type
label
Corifollitropin α followed by ...... multicentre randomised trial.
@en
prefLabel
Corifollitropin α followed by ...... multicentre randomised trial.
@en
P2093
P2860
P1433
P1476
Corifollitropin α followed by ...... multicentre randomised trial.
@en
P2093
Joaquin Llacer
Konstantinos Pantos
Michel Camus
Nikolaos P Polyzos
P2860
P356
10.1136/BMJOPEN-2013-002938
P577
2013-06-20T00:00:00Z